Flonase, Zaditor DTC Ads Cited By FDA; Both Allergy Campaigns Are Over

FDA is directing GlaxoSmithKline and Novartis to revise direct-to-consumer ads for allergy products attempting to capitalize on the changes in the market following the OTC switch of Claritin